Free shipping on all orders over $ 500

PLX5622

Cat. No. M9512

All AbMole products are for research use only, cannot be used for human consumption.

PLX5622 Structure
Synonym:

PLX5622 free base; PLX-5622

Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
2mg USD 40 In stock
5mg USD 90 In stock
10mg USD 150 In stock
25mg USD 300 In stock
50mg USD 440 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

PLX5622 is a highly selective brain penetrant and oral active CSF1R inhibitor with an Ki of 5.9 nM. PLX5622 eliminates microglia from the brain, which can be sustained in wild-type and the Alzheimer's disease model mice (3xTg-AD model). In the AD model PLX5622 prevents microglial association with amyloid β plaques and improves cognition.

In vivo, PLX5622 (65 mg/kg/day; oral gavage for 14 days) causes paw withdrawal threshold high in mice, indicating that PLX5622 prevents the development of injury-associated mechanical allodynia.

Product Citations
Protocol (for reference only)
Cell Experiment
Cell lines
Preparation method
Concentrations
Incubation time
Animal Experiment
Animal models
Formulation
Dosages
Administration
Chemical Information
Molecular Weight 395.41
Formula C21H19F2N5O
CAS Number 1303420-67-8
Solubility (25°C) DMSO ≥ 65 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Spangenberg E, et al. Nat Commun. Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer's disease model.

[2] Yiting Liu, et al. Exp Neurol . Concentration-dependent effects of CSF1R inhibitors on oligodendrocyte progenitor cells ex vivo and in vivo

[3] Lee S, et al. Mol Pain. Targeting macrophage and microglia activation with colony stimulating factor 1 receptor inhibitor is an effective strategy to treat injury-triggered neuropathic pain.

Related CSF-1R (c-Fms) Products
GW2580

GW2580 is a selective CSF-1R inhibitor for c-FMS with IC50 of 30 nM, 150- to 500-fold selective compared to b-Raf, CDK4, c-KIT, c-SRC, EGFR, ERBB2/4, ERK2, FLT-3, GSK3, ITK, JAK2 etc.

PLX647

PLX647 is a highly specific dual FMS/KIT kinase inhibitor with IC50 of 28/16 nM respectively.

BLZ945 (Sotuletinib)

Sotuletinib (BLZ945) is an orally active, potent and selective CSF-1R inhibitor with IC50 of 1 nM, >1000-fold selective against its closest receptor tyrosine kinase homologs.

Ki 20227

Ki 20227 is a c-Fms inhibitor; suppresses osteolysis and osteoclast accumulation.

cFMS Receptor Inhibitor II

cFMS Receptor Inhibitor II is a CSF1R kinase inhibitor.

  Catalog
Abmole Inhibitor Catalog




Keywords: PLX5622, PLX5622 free base; PLX-5622 supplier, CSF-1R (c-Fms), inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.